Coupons are provided to acquire "Bound Yuanbao" and "EXP Fairy" aiding in character growth. An event is held every weekend… offering a variety of items that help with quick growth

SEOUL, South Korea, March 8, 2024 /PRNewswire/ — ChuanQi IP, a subsidiary of Wemade (CEO: Henry Chang), will offer two growth-supporting events in celebration of the one-month anniversary of MIR2M: The Grandmaster, the new blockchain-based idle martial arts RPG.

ChuanQi IP’s idle RPG, MIR2M: The Grandmaster offers a one-month anniversary event! ChuanQi IP’s idle RPG, MIR2M: The Grandmaster offers a one-month anniversary event!

First, new users are provided with coupons to obtain 100 "Bound Yuanbaos" and one "EXP Fairy." Coupons are shared through MIR2M social channels, and users can use them by entering the code in the in-game Benefit Hall menu.

Every Friday, Saturday, and Sunday, an event takes place. Participants can join using Yuanbaos or tickets. Over 310 items, including "Alien Beast" and "Collection Cards" for quick growth, are distributed as event rewards.

MIR2M: The Grandmaster, released in February, is the third title in the MIR2M series. It features rich content like PvP battles, boss dungeons, and guild systems. Players can create parties with up to five characters of various classes such as warriors, mages, and Taoists, nurturing them simultaneously.

Detailed information about the game and events can be found on the official MIR2M: The Grandmaster website and the global blockchain platform WEMIX PLAY.

Reference Sites:

MIR2M: The Grandmaster Official Site: https://thegrandmaster.mir2m.world/ MIR2M: The Grandmaster Download: https://mir2mthegrandmaster.go.link?adj_t=18ngvfyc Official WEMIX Play Site: https://wemixplay.com/

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype

The secondary analysis of the PACE trial highlights the value of counting…

Farmmi Receives NASDAQ Notification Regarding Minimum Bid Requirements

LISHUI, China, April 27, 2024 /PRNewswire/ — Farmmi, Inc. ("Farmmi" or the…

Focus on Smart, Green, Experience retail, 2024 CHINASHOP opening in Shanghai

SHANGHAI, March 14, 2024 /PRNewswire/ — On March 13, 2024, CHINASHOP was…